Annexin Pharmaceuticals

Stockholm, Sweden

Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.

$674K raised

Dec 2022

Post-IPO Equity

Biotechnology Health Care

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Annexin Pharmaceuticals

How much funding has Annexin Pharmaceuticals raised?

Annexin Pharmaceuticals has raised $674K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2022.

Where is Annexin Pharmaceuticals headquartered?

Annexin Pharmaceuticals is headquartered in Stockholm, Sweden.

What does Annexin Pharmaceuticals do?

Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.

What stage is Annexin Pharmaceuticals at?

Annexin Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2022.

MLA

"Annexin Pharmaceuticals — Funding & Investors." VCBacked, December 19, 2022, https://www.vcbacked.co/company/annexin-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2022). Annexin Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/annexin-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Annexin Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/annexin-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2022.